Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback